Zyloprim is the brand name for the drug allopurinol, a medication used to lower uric acid levels in the blood. It is classified as a xanthine oxidase inhibitor that reduces the production of uric acid by blocking the enzyme responsible for its synthesis. By decreasing uric acid concentration, the drug helps prevent gout attacks and the formation of uric acid crystals in joints. The therapeutic role of Zyloprim is to manage chronic gout and to reduce the risk of kidney stones caused by hyperuricemia. It is administered orally in tablet form and is typically taken once daily after meals to minimize gastrointestinal irritation. The mechanism of action involves binding to the active site of xanthine oxidase, preventing the conversion of xanthine to uric acid. This inhibition lowers serum uric acid levels, which reduces inflammation and crystal deposition in affected tissues. Clinical response is usually observed within several weeks, and dosage adjustments may be guided by laboratory monitoring of uric acid concentrations.

Zyloprim is the brand name for the drug allopurinol, a medication used to treat conditions caused by excess uric acid. It works by inhibiting the enzyme xanthine oxidase, which reduces the production of uric acid in the body. By lowering uric acid levels, Zyloprim helps prevent the formation of painful crystals that can deposit in joints and kidneys. The reduced crystal formation decreases the frequency of gout attacks and slows the progression of kidney stones. The drug is absorbed in the gastrointestinal tract and is metabolized slowly, providing a long lasting therapeutic effect. Allopurinol's pharmacological action involves converting to its active form, oxypurinol, which binds to the active site of xanthine oxidase. This binding blocks the enzyme's ability to convert hypoxanthine and xanthine into uric acid, thereby decreasing overall serum uric acid concentration. The sustained reduction in uric acid alleviates inflammation and tissue damage associated with hyperuricemic conditions.

Zyloprim can cause skin rash allergic reactions and liver enzyme elevations in some patients. It may also lead to gastrointestinal discomfort such as nausea diarrhea or abdominal pain. Rarely it can produce severe hypersensitivity syndromes including stevens johnson syndrome. The medication can interact with azathioprine causing increased toxicity in certain individuals. Monitoring of kidney function is recommended because dose adjustments may be needed. Most side effects are mild and resolve when the drug is discontinued.

Zyloprim may cause skin rash in some patients. It can occasionally lead to liver enzyme abnormalities. Some individuals experience gout flare-ups after starting treatment. Kidney function may be affected in people with pre-existing conditions. Allergic reactions such as swelling or difficulty breathing have been reported rarely. Bone marrow suppression is an uncommon but serious adverse effect. The frequency of these effects varies with dosage and patient health history.